Answers are grounded in this paper and cite their sources.
Purpose To assess clinical outcomes after hip preservation surgery for patients grouped into the 3 following conditions: dysplasia, femoroacetabular impingement (FAI), or isolated labral tears. Methods Patients who underwent hip preservation surgery at our center between January 2018 and December 2021 were identified. Patients with dysplasia, FAI, or isolated labral tears were included. Clinical outcomes of the 3 condition groups were compared using the International Hip Outcome Tool‐12 and Patient‐Reported Outcomes Measurement Information System, which were collected preoperatively and at 3 months and 1 and 2 years postoperatively. Results A total of 378 patients were included: 80 (22.4%) with dysplasia, 173 (48.6%) with FAI, and 103 (28.9%) with isolated labral tears. Arthroscopy (n = 269, 75.6%) was the most common procedure, followed by periacetabular osteotomy (n = 82, 23.0.4%) and surgical dislocation (n = 7, 2.0%). All groups had significant improvements in their International Hip Outcome Tool‐12 and Patient‐Reported Outcomes Measurement Information System physical ( P < .001). There were no significant differences between the 3 primary groups except with dysplasia at 3 months ( P = .018). The percentages of patients attaining minimal clinically important difference on the International Hip Outcome Tool‐12 at 1 year showed a significant difference between the 3 groups: 35.9% (FAI), 63.2% (dysplasia), and 48.6% (labral tears), P = .028. Reoperation rates, according to condition groups, were higher for dysplasia mainly because of the removal of internal fixation and similar between FAI and labral tear. Conclusions In this study, we observed significant improvements in the patient‐reported outcome measures after hip preservation surgery for dysplasia, FAI, and isolated labral tears. Although dysplasia patients showed slower recovery and a higher reoperation rate, both the dysplasia and isolated labral tear groups were comparable in achieving minimal clinically important difference and substantial clinical benefit, whereas the FAI group had significantly lower percentages of patients achieving them. Level of Evidence Level III, therapeutic retrospective comparative study.
No takes yet. Share an insight, caveat, or question.
Ricard et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: